| 221/425 | US=23-A / Câncer Toledo F. Role of TP53 mutations in cancer (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 75-92. ISBN 978-1-4020-8441-62. |
| 222/425 | US=23-A / Câncer Welsh SJ, Powis G. Personalized medicine for cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 93-107. ISBN 978-1-4020-8441-62. |
| 223/425 | US=23-A / Câncer Compagnone G. Radiation doses to patients using computed radiography, direct digital radiography, and screen-film radiography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 109-28. ISBN 978-1-4020-8441-62. CANCER; RADIACAO. DOSAGEM; RADIOGRAFIA COMPUTADORIZADA; RADIOGRAFIA DIGITAL DIRETA; FILME RADIOGRAFICO; DOSIMETRIA; SISTEMAS CONVENCIONAIS TELA/FILME |
| 224/425 | US=23-A / Câncer Tabi Z, Man S. Cancer vaccines and immune monitoring (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 129-59. ISBN 978-1-4020-8441-62. CANCER; VACINA; MONITORAMENTO IMUNOLOGICO; VACINA PROFILATICA; HPV; PAPILOMAVIRUS HUMANO; CANCER CERVICAL; HEPATITE B; CANCER DE FIGADO; HEPATITE C; VACINAS TERAPEUTICAS; VACINAS DE CELULAS DENDRITICAS; TRANSFERENCIA DE CELULAS ADOTIVA T; IMUNOESTIMULANTES INESPECIFICOS; MODIFICADORES DA RESPOSTA IMUNE; QUIMIOTERAPIA; RADIOTERAPIA; MONITORAMENTO DE RESPOSTAS IMUNES; ENSAIOS DE PROLIFERACAO; ENSAIOS DE CITOTOXICIDADE; ENSAIOS DE SECRECAO DE CITOCINAS; TETRAMEROS |
| 225/425 | US=23-A / Câncer Grandics P. New insights into the role of infection, immunity and apoptosis in the genesis of the cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 161-77. ISBN 978-1-4020-8441-62. |
| 226/425 | US=23-A / Câncer Dingli D, Pacheco JM. Successful cancer treatment: eradication of cancer stem cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 179-91. ISBN 978-1-4020-8441-62. CANCER; CELULAS-TRONCO; CANCER. TRATAMENTO; ERRADICACAO DO CANCER; MARCADORES |
| 227/425 | US=35 / Estatística Rushton G, Cai Q, Chen Z. Producing spatially continuous prostate cancer maps with different geocodes and spatial filter methods. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 69-90. ISBN 0-8493-8419-2. PRODUTORAS DE MAPAS ESPACIALMENTE CANCER DE PROSTATA; GEOCODES DIFERENTES; MAPAS DE CANCER; TAXAS DE MORTALIDADE CANCER DE PROSTATA |
| 228/425 | US=23-A / Câncer Clewer P. Overexposure of patients to ionizing radiation: an overview. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 193-200. ISBN 978-1-4020-8441-62. CANCER; RADIACAO IONIZANTE; SUPEREXPOSICAO; RADIACAO; MEDICINA NUCLEAR; RADIOTERAPIA |
| 229/425 | US=23-A / Câncer Hayat MA. Lung carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 203-6. ISBN 978-1-4020-8441-62. |
| 230/425 | US=23-A / Câncer Shahid RK, Haider K, Sami A, Imran A, Arnold F, Yadav S, Harding K, Brigden M, Popkin D, Ahmed S. Extra-pulmonary small cell cancer: diagnosis, treatment, and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 207-17. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PEQUENAS CELULAS EXTRA-PULMONAR; DIAGNOSTICO; TRATAMENTO; PROGNOSTICO; CARCINOMA DE PEQUENAS CELULAS. EPIDEMIOLOGIA; CARCINOMA DE PEQUENAS CELULAS. DIAGNOSTICO; CARCINOMA DE PEQUENAS CELULAS. TRATAMENTO; CARCINOMA DE PEQUENAS CELULAS. PROGNOSTICO; TRATO GENITOURINARIO; TRATO GASTROINTESTINAL; CABECA E PESCOCO; MAMA |
| 231/425 | US=23-A / Câncer Sensakovic WF, Armato III SG. Magnetic resonance imaging of the lung: automated segmentation methods. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 219-34. ISBN 978-1-4020-8441-62. CANCER; PULMAO; RESSONANCIA MAGNETICA; SEGMENTACAO AUTOMATICA. METODOS; RESSONANCIA MAGNETICA TORACICA; METODOS DE SEGMENTACAO AUTOMATIZADA; OPERADORES DE LIMIARIZACAO; DESCRITORES DE FORMA; PARAMETRICOS CONTORNOS ATIVOS; REDE NEURAL; COMBINACAO CONTORNO ATIVO |
| 232/425 | US=23-A / Câncer Gorg C, Holland A. Peripheral lung lesions: diagnosis using transcutaneous contrast-enhanced sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 235-45. ISBN 978-1-4020-8441-62. CANCER; LESOES PULMONARES PERIFERICAS; ULTRA-SONOGRAFIA TRANSCUTANEA; VASCULARIZACAO PULMONAR; ULTRA-SONOGRAFIA COM CONTRASTE |
| 233/425 | US=23-A / Câncer Das M. Small pulmonary nodules: detection using multidetector-row computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 247-60. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; NODULOS PULMONARES; TOMOGRAFIA COMPUTADORIZADA; GRANULOMA; HARMATOMA; METASTASE |
| 234/425 | US=23-A / Câncer Takigawa N, Segawa Y, Kiura K. Secondary primary cancer following chemoradiation for non-small-cell lung cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 261-7. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; QUIMIORRADIACAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS |
| 235/425 | US=23-A / Câncer Gridelli C, Maione P. Advanced non-small cell lung cancer: second-line treatment with docetaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 269-80. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; DOCETAXEL; TRATAMENTO |
| 236/425 | US=23-A / Câncer Nelli F, Moscetti L. Non-small cell lung cancer with brain metastases: platinum-based chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 281-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; METASTASES CEREBRAIS; QUIMIOTERAPIA; PLATINA |
| 237/425 | US=23-A / Câncer Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 238/425 | US=23-A / Câncer Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 239/425 | US=23-A / Câncer Nomori H. Prognostic significance of [18F]-Fluorodeoxyglucose uptake on positron emission tomography in patients with pathological stage I lung adenocarcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 317-22. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; PROGNOSTICO; [18F]-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; ESTADIO PATOLOGICO I; ADENOCARCINOMA DE PULMAO |
| 240/425 | US=23-A / Câncer Pfannschmidt J, Bulzebruck H, Dienemann H. Non-small cell lung cancer: prognosis using the TNM staging system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 323-36. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; PROGNOSTICO; SISTEMA TNM; CLASSIFICACAO DE TUMORES MALIGNOS |